Radiotherapy with Targeted Therapy or Immune Checkpoint Inhibitors for Hepatocellular Carcinoma with Hepatic Vein and/or Inferior Vena Cava Tumor Thrombi

• DOI: 10.2147/jhc.s464140
• Publication Date: 2024-08-05T07:35:13Z
• Authors: Zhuoran Li; Yirui Zhai; Fan Wu; Dayong Cao; Feng Ye; Yan Song; Shulian Wang; Yueping Liu; Yongwen Song; Yuan Tang; Hao Jing; Hui Fang; Shunan Qi; Ningning Lu; Ye-Xiong Li; Jianxiong Wu; Bo Chen
• Keywords: Targeted Therapy

This study evaluated the clinical outcomes of patients with hepatocellular carcinoma (HCC) hepatic vein tumor thrombus (HVTT) and/or inferior vena cava (IVCTT) receiving radiotherapy (RT) combined systemic therapies.